🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective single arm, multi-center, phase II clinical trial to ...
Status
Suspended
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2020-12-25
Trial ID
NCT04668365
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of glofita...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2022-11-16
Trial ID
NCT05533775
Treatments Being Tested
This study evaluates the addition of selinexor (KPT-330) to RICE chemothera...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2015-12-11
Trial ID
NCT02471911
Treatments Being Tested
This research is being done to see if a PET scan that is obtained after 3 c...
Status
Terminated
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2009-01
Trial ID
NCT00809341
RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells ...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1999-11
Trial ID
NCT00005631
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of lenalidomid...
Status
Unknown
Location
Mayo Clinic in Florida
Start Date
2016-05-20
Trial ID
NCT02628405
Treatments Being Tested
This is an open-label, multicentre, randomised phase II trial in relapsed o...
Status
Active Not Recruiting
Location
The Beatson West of Scotland Cancer Centre
Start Date
2022-06-27
Trial ID
NCT05221645
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of vorinos...
Status
Completed
Location
Puget Sound Oncology Consortium
Start Date
2007-12
Trial ID
NCT00601718
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2006-09-26
Trial ID
NCT00274924
To evaluate the preliminary efficacy of JS203 combined with standard regime...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-08-17
Trial ID
NCT07081022